
Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …

Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …

Amgen has seen its drug Kyprolis (carfilzomib) rejected by NICE for its routine use in the treatment of multiple myeloma …

It’s easy to say that Valeant hasn’t had a great year so far. Unfortunately for those concerned, the outlook for …

BenevolentAI, a British artificial intelligence company, announced a licensing agreement to develop a select number of drug candidates with Janssen, …

vasopharma, a privately held biopharmaceutical company, announced on 8 November that it had appointed Irina Antonijevic as their chief medical …

There is only one more day to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

The FDA has given 510(k) clearance to a smart inhaler sensor developed by Propeller Health for use with GlaxoSmithKline’s Ellipta …

Coherus Biosciences, a developer of biosimilars, has suffered a blow in their petition for Inter Partes Review (IPR) of one …

Teva has received the approval from the US Food and Drug Administration (FDA) for its generic hypertension treatments Tribenzor (olmesartan …

Oystein Soug was announced as the new CEO of Targovax, a clinical stage immuno-oncology company dedicated to the development of …

Biogen and Ionis Pharmaceuticals have released news that their investigational treatment for spinal muscular atrophy (SMA), Spinraza (nusinersen), met the …

There are only two more days to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

South Korea’s pharmaceutical workforce has expanded by 27% in the last four years. The growth in jobs is can be …

GlaxoSmithKline has filed a patent infringement lawsuit against rival Pfizer over the alleged copying of its popular meningococcal group B …

Amgen’s Enbrel has been given approval by the FDA for expanded use to treat children with chronic moderate-to-severe plaque psoriasis. …

Cancer Research UK (CRUK) and its commercial arm, Cancer Research Technology (CRT), haven entered into an agreement with TYG Oncology …

Nestle Health Science has invested $145 million in return for a 15% stake in Aimmune Therapeutics. Aimmune pursues food-allergy therapies …
Merck KGaA inaugurated their Nantong pharmaceutical plant on 4 November. At the same time, Merck also announced that it plans …

This week has seen pharmaceutical companies release their third quarter profits, good news for some whilst others have attempted to …